The Medicines Company Reports Second Quarter and First Half 2008 Financial Results and Raises...

yahoo.com     Jul 23, 2008            

Wednesday July 23, 8:00 am ET PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO - News ) today announced its financial results for the second quarter and first half of 2008. Financial highlights for the second quarter of 2008: Angiomax® (bivalirudin) U.S. sales increased by 53% to $84.5 million for the second quarter of 2008 from $55.2 million for the second quarter of 2007. Excluding stock-based compensation expense and non-cash income taxes, the Company reported second quarter of 2008 non-GAAP net income of $14.5 million, or $0.28 per share, compared to non-GAAP net income of $5.1 million, or $0.10 per share, for the second quarter of 2007. John Kelley, President and Chief Operating Officer, stated, “We continue to execute our Angiomax strategy to gain market share and further penetrate the PCI market.... [read full story]                    

Full Coverage
1 2 3 4 next »